Choosing which test to pay for, given a fixed budget — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below.
A question about how a record should be read rather than about a supplier.
We have results from Janoshik and from PeptideMeter on the same product line, months apart, agreeing closely. My question is what that agreement actually establishes, given that neither saw the other's sample.
I suspect the honest answer is narrower than it feels, and I would like it stated precisely.